Smartphone-powered population health screening
Identify patients most at risk of kidney and cardiovascular disease with at-home testing
Easing the burden of chronic conditions
- The global rise in life expectancy and other improvements to health has been coupled with an increase in long-term chronic conditions
- One of the key challenges facing health systems is to find the best ways to identify and treat those most at risk
- Events such as kidney failure, and cardiovascular events such as strokes and heart attacks are highly prevalent and very costly—but are preventable in many cases
- The people at greatest risk of these events have commonly occurring conditions such as diabetes and hypertension
- Members of lower socio-economic and BAME groups are at an even higher risk—a key target of the NHS's Core20PLUS5 approach
- Our goal: find patients who need action, and free up clinicians to focus on those patients
The missing puzzle piece
- Clinicians and health systems are fighting an uphill battle to treat and prevent chronic conditions and adverse events
- Clinicians are likely checking patients’ kidney function, their blood sugar, and counselling them about obesity, smoking and other lifestyle risk factors
- But one key test is often overlooked. Albumin-to-creatinine ratio (ACR), obtained via a urine sample, measures kidney damage directly and provides a strong early marker of kidney disease, allowing for early intervention and management. It also serves as an important early risk predictor of cardiovascular disease.
- More than half of people with type 2 diabetes do not take the recommended annual test. Less than a third of people with hypertension are tested. The lack of testing has created a so-called “missing million” of undiagnosed people.
Digital clinical-grade testing
Minuteful Kidney is helping to make digital testing the new normal, in line with the new NHS Operational Planning Guidance. ICBs are seeing the impact of increasing adherence in areas where MK has been deployed across.
Digital testing uses the same point of care dipsticks as lab testing and generates equivalent results. It measures semi quantitative analysis of microalbumin (10 – 150 mg/L), creatinine (10 – 300mg/dL) and albumin to creatinine ratio (mg/g).
Results are expressed as ACR normal (<30mg/g), ACR abnormal (30-300mg/g) or ACR high abnormal (>300mg/g).
The product is CE marked, GDPR compliant, and follows industry standards for privacy and safety.
How it works
Reach patients who have not tested in the last 12 months by allowing them to test at home when it’s most convenient.
Send
Test kits can be used directly by untested patients who are identified through a simple search in SystmOne or EMIS
Test
Patients test at home using our test kit with help from our virtual nurse, Emily, who guides them throughout the entire exam
Get results
Results are analysed and uploaded to SystmOne or EMIS workflows in real time so GPs can access them directly
Book a meeting
To learn more about how Minuteful Kidney can benefit your organisation, just fill out this form to book a meeting with us.
